This study was run to evaluate whether provider specialty is a driver for biosimilar adoption, defined as adoption probability difference (APD). Diane Faraone, PharmD, Russell Robbins, MD, MBA, Grace Kane, MS, Douglas Londono, PhD.  The US biologics market has significantly expanded in recent years; projected to reach $62 billion in prescription drug spend by 2025. Biosimilar…

Study is to assess the SARS-CoV-2 antibody levels over time (2021-2022), measured with the Elecsys Anti-SARS-COV-2 S assay, in the real-world setting, and assess the association between them and subsequent COVID-19 outcomes. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon presented a poster during ISPE 2024. The objective of this…

 PurpleLab®, the healthcare analytics platform with one of the largest medical and pharmaceutical databases in the United States, announced today the introduction of Audience Builder, a new solution for advertisers that simplifies the use of complex healthcare data. This planning tool is designed specifically to meet the unique needs of advertisers and digital media buyers. …

The company announced the introduction of Alerts to empower stakeholders in the healthcare industry with the most updated and easy-to-understand insights. Wayne, Pennsylvania. Monday, June 3, 2024 – PurpleLab®, a healthcare analytics company that holds one of the largest medical and pharmaceutical claims databases in the US, announced the launch of Alerts today, adding a…

Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…

The company announced the introduction of CLEAR Claims , a solution to help generate faster insights from claims data, helping users answer business questions to drive improved patient outcomes. Wayne, Pennsylvania. Tuesday, August 29, 2023 — PurpleLab™, a healthcare analytics company that holds one of the largest claims databases in the US, announced today the launch of…

The investment highlights PurpleLab’s™ growing role in simplifying the access to and interpretation of Real-World Data (RWD) across the healthcare continuum.

There are currently less than 20 companies that have earned this rigorous certification.

By understanding inequities and disparities in prescription fill rates with SDOH, we can implement changes for the patients and physicians treating them through better education, rebates, or understanding why the barriers exist.